ArticleJournal of clinical medicine2026
Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study.
Einav Koren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.